Findings

What do systematic reviews say?

2,079 questions · 2,112 findings · 171 reviews · Eyes and Vision

Sort:Best matchNewestHighest certainty Download CSV

No studies found 587 · 27.8%GRADE not reported 95 · 4.5%Very low 446 · 21.1%Low 557 · 26.4%Moderate 361 · 17.1%High 66 · 3.1%

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs macular laser

Change in visual acuity (logMAR) ‐ 12 months (negative is better) · adults with centre‐involving diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs macular laser

Gain or loss of 10 or more letters visual acuity at 1 year · adults with centre‐involving diabetic macular oedema

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Change in distance BCVA, between baseline and 12 months · adults undergoing cataract surgery with IOL implantation

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 131 participants
Moderate

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

BCVA: loss of 15 or more ETDRS letters · adults undergoing cataract surgery with IOL implantation

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 63 participants
Very low

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Contrast sensitivity function, measured in log Contrast Sensitivity at six months · adults undergoing cataract surgery with IOL implantation

The review found no eligible studies for this question.

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Colour discrimination, measured as the proportion of eyes that had a measurable loss from baseline using Farnsworth‐Munsell 100‐hue colour test score under photopic conditions at six months · adults undergoing cataract surgery with IOL implantation

The review found no eligible studies for this question.

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Proportion of participants with adverse events with a probable causal link with the study interventions at six months · adults undergoing cataract surgery with IOL implantation

The review found no eligible studies for this question.

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Late AMD · adults undergoing cataract surgery with IOL implantation

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

Proportion of eyes that developed any stage of AMD at 12 months · adults undergoing cataract surgery with IOL implantation

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 144 participants
Very low

Any quality improvement intervention vs usual care

Proportion of participants attending screening (median · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
56 studies · 329164 participants
Low

Any quality improvement intervention vs usual care

Ongoing adherence to screening · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

The review found no eligible studies for this question.

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any quality improvement intervention vs usual care

Economic Outcomes Resources used (staff time, equipment, consumables) · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 85 participants
Low

Any quality improvement intervention vs usual care

Staff/personnel costs; costs of treatment and care; cost of primary care; lost wages and lost productivity · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 85 participants
Low

Any quality improvement intervention vs usual care

Incremental cost‐effectiveness · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 85 participants
Low

Stepped quality improvement intervention vs the intervention alone

Proportion of participants attending screening (median · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 23715 participants
Moderate

Stepped quality improvement intervention vs the intervention alone

Ongoing adherence to screening · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

The review found no eligible studies for this question.

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stepped quality improvement intervention vs the intervention alone

Economic outcomes · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening

The review found no eligible studies for this question.

1 finding from 1 review

Interventions to increase attendance for diabetic retinopathy screening 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Descemet’s membrane endothelial keratoplasty (DMEK) vs Descemet’s stripping automated endothelial keratoplasty (DSAEK)

Postoperative mean logMAR BCVA at 1 year · participants/eyes with corneal endothelial failure

1 finding from 1 review

Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Descemet’s membrane endothelial keratoplasty (DMEK) vs Descemet’s stripping automated endothelial keratoplasty (DSAEK)

Severe visual loss (LogMAR BCVA of 1.0 or more) within 12 months' · participants/eyes with corneal endothelial failure

1 finding from 1 review

Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Descemet’s membrane endothelial keratoplasty (DMEK) vs Descemet’s stripping automated endothelial keratoplasty (DSAEK)

Endothelial cell count cells/mm2, 12 months' · participants/eyes with corneal endothelial failure

1 finding from 1 review

Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low